Our group recently demonstrated that the BCPAP thyroid cancer cell line, harboring the BRAFV600E mutation, does secrete high amounts of CXCL8 both in basal culture conditions and after incubation with TNFα17. This evidence concerns the gene CXCL8 and thyroid cancer.